Specifications
- Purity
- ≥97% (HPLC)
- Appearance
- White to off-white powder
Properties
- Solvents
- Soluble in DMF (20 mg/ml), DMSO (20 mg/ml), ethanol (20 mg/ml).
Category: Vitamins
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
1α-Hydroxyvitamin D3 is a synthetic analog of vitamin D used extensively in biomedical research and clinical studies for its potent calcium-regulating properties. Ths prodrug is rapidly converted by cytochrome P450 isoforms in the liver to the active metabolite 1α,25-dihydroxyvitamin D3, bypassing the need for renal 1α-hydroxylation. This makes it particularly valuable in studying calcium and phosphate homeostasis, bone metabolism, and the treatment of disorders like osteoporosis and chronic kidney disease-related mineral and bone disorder (CKD-MBD). 1α-Hydroxyvitamin D3 is a non-selective VDR activator and used to explore vitamin D receptor (VDR) signaling, immune modulation, and potential anti-inflammatory and anti-proliferative effects across various cell types. Compound can be used as analytical reference material.
| Synonyms | 1&alpha,-Hydroxycholecalciferol, Alfacalcidol, &alpha,-Calcidol, Etalpha, 1-hydroxy Cholecalciferol, Tevabone, Alpha D3, 1&alpha,-OH-D3 |
|---|---|
| Purity | ≥97% (HPLC) |
| Appearance | White to off-white powder |
| CAS-Number | 41294-56-8 |
| Molecular Formula | C27H44O2 |
| Molecular Weight | 400.64 |
| Solvents | Soluble in DMF (20 mg/ml), DMSO (20 mg/ml), ethanol (20 mg/ml). |
| Smiles | C[C@@]12[C@](CC[C@]2([H])[C@H](C)CCCC(C)C)([H])/C(CCC1)=C/C=C3C([C@H](C[C@@H](C\3)O)O)=C |
| InChi Key | OFHCOWSQAMBJIW-AVJTYSNKSA-N |
| Shipping | AMBIENT |
| Short Term Storage | -20°C |
| Long Term Storage | -20°C |
| Handling Advice | Protect from light and moisture. |
| Use / Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Hazard statements | H300 |
| Precautionary statements | P301 + P330 + P331 + P310 |
| GHS Symbol | GHS06 |
| Signal word | Danger |
| RIDADR | UN2811 |
| Transportation | Packing Group I |
| References | (1) J.E. Zerwekh, et al., Biochem. 13, 4097 (1974), (2) N. Takeshita, et al., Life Sci. 56, 1095 (1995), (3) A. Shiraishi, et al., Calcif. Tissue Int. 65, 311 (1999), (4) R.A. Upton, et al., Nephrol. Dial. Transplant 18, 750 (2003), (5) R. Nuti, et al., Rheumatol. Int. 26, 445 (2006), (6) R.C. Tuckey, et al., J. Steroid Biochem. Mol. Biol. 112, 213 (2008), (7) N. Kubodera, Molecules 14, 3869 (2009), (8) C.S. Ritter & A.J. Brown, J. Mol. Endocrinol. 46, 63 (2011), (9) T. Suda, et al., Arch. Biochem. Biophys. 523, 22 (2012) |
| InChi | InChI=1S/C27H44O2/c1-18(2)8-6-9-19(3)24-13-14-25-21(10-7-15-27(24,25)5)11-12-22-16-23(28)17-26(29)20(22)4/h11-12,18-19,23-26,28-29H,4,6-10,13-17H2,1-3,5H3/b21-11+,22-12-/t19-,23-,24-,25+,26+,27-/m1/s1 |
| Quantity | 5 mg, 10 mg, 25 mg, Bulk |

Itraconazole